Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001214659-26-014040·Juniper Investment Company, LLC
Schedule 13D ownership disclosure
Orthofix Medical Inc
Common stock, $0.10 par value per share · CUSIP: 68752M108
Event date: 2026-11-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Juniper Targeted Opportunity Fund, L.P.Reported CIK 0001524397
Shares: 4,461,019.00 · Class: 10.9%
- Juniper HF Investors II, LLC
Shares: 4,461,019.00 · Class: 10.9%
- Juniper Targeted Opportunities, L.P.Reported CIK 0001680619
Shares: 935,901.00 · Class: 2.3%
- Juniper Targeted Opportunity Investors, LLC
Shares: 935,901.00 · Class: 2.3%
- Juniper Multi-Strategy Fund, L.P.
Shares: 84,926.00 · Class: 0.2%
- Juniper HF Investors, LLC
Shares: 84,926.00 · Class: 0.2%
- Juniper Investment Company, LLCReported CIK 0001794034
Shares: 5,481,846.00 · Class: 13.4%
- Alexis P. MichasReported CIK 0001044005
Shares: 5,481,846.00 · Class: 13.4%
- John A. BartholdsonReported CIK 0001382909
Shares: 5,481,846.00 · Class: 13.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-26-014040
- Form type
- SCHEDULE 13D/A
- Filer
- Juniper Investment Company, LLC
- CIK
- CIK 1794034
- Filed
- Nov 12, 2026
- Reporting period
- Nov 09, 2026
- Description
- Schedule 13D beneficial ownership